Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
Amphastar Pharmaceuticals, Inc.
(NASDAQ:AMPH)
$34.66
$-0.69
-1.95%
Amphastar Pharmaceuticals, Inc. Chart
AMPH Stock Price Today
Amphastar Pharmaceuticals, Inc. (AMPH) stock declined over -1.95% intraday to trade at $34.66 a share on NASDAQ. The stock opened with a gain of 2.64% at $34.75 and touched an intraday high of $35.41, falling -0.37% against the last close of $34.79. The stock went to a low of $34.42 during the session.
Stock Snapshot
$34.79
Prev. Close
1.67 Billion
Market Cap
$34.42
Day Low
$34.75
Open
48.14 Million
Number of Shares
$35.41
Day High
21.54
P/E ratio
1.61
EPS (TTM)
2.84
Cash Flow per Share
6.86
Free Float in %
8.97
Book Value
436,569
Volume
Amphastar Pharmaceuticals, Inc. Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-07-01 | $34.75 | $35.41 | $34.42 | $35.35 | 408,500 |
| 2022-06-30 | $33.77 | $35.3 | $33.69 | $34.79 | 748,900 |
| 2022-06-29 | $33.52 | $34.49 | $32.54 | $34.15 | 331,800 |
| 2022-06-28 | $34.18 | $34.39 | $32.9 | $33.25 | 291,500 |
| 2022-06-27 | $32.22 | $34.69 | $31.94 | $34.28 | 375,700 |
| 2022-06-24 | $32.89 | $33 | $31.52 | $31.78 | 1,255,800 |
| 2022-06-23 | $31.72 | $32.9 | $31.72 | $32.74 | 515,700 |
| 2022-06-22 | $31.35 | $32.38 | $31.3 | $31.71 | 361,500 |
| 2022-06-21 | $31.98 | $32.5 | $31.13 | $31.61 | 420,800 |
| 2022-06-17 | $31.35 | $32.57 | $31.27 | $31.52 | 1,116,500 |
Contact Details
Company Information
Employees-
Beta0.67
Sales or Revenue437.77 Million
5Y Sales Change11.40%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
About Company
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Frequently Asked Questions
What is the current Amphastar Pharmaceuticals, Inc. (AMPH) stock price?
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stock price is $34.66 as of the last check on Friday, July 1. During the trading session, AMPH stock reached the peak price of $35.41 while $34.42 was the lowest point it dropped to.
AMPH's industry and sector of operation?
The NASDAQ listed AMPH is part of Pharmaceuticals industry that operates in the broader Health Care sector. Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
Who are the executives of AMPH?
Dr. Yongfeng Zhang
Co-founder, Pres, CEO, Chief Scientific Officer & Director
Mr. William J. Peters M.B.A.
CFO, Treasurer & Exec. VP of Fin.
Mr. Jacob Liawatidewi M.B.A.
Exec. VP of Corp. Admin. Center, Sales & Marketing and Corp. Sec.
Dr. Ziping Luo Ph.D.
Chairman, Chief Scientist & COO
What is the AMPH stock price today?
AMPH stock traded closed the last session at $35.35, which is $-0.69 or -1.95% lower than its previous close of $34.79. AMPH's current trading price is 97.38% lower than its 52-week high of $44.46 where as its distance from 52-week low of 17.56% is -22.04%.
How many employees does AMPH have?
Number of AMPH employees currently stands at -. AMPH operates from 11570 6th Street, Rancho Cucamonga, CA 91730, United States.
Link for AMPH official website?
Official Webiste of $AMPH is: https://www.amphastar.com
How do I contact AMPH?
AMPH could be contacted at AMPH operates from 11570 6th Street, Rancho Cucamonga, CA 91730, United States, or at phone #909 980 9484 and can also be accessed through its website.
How many shares of AMPH are traded daily?
AMPH stock volume for the day was 436,569 shares while in the previous session number of AMPH shares traded was 408,500 . The average number of AMPH shares traded daily for last 3 months was 622.04 Thousands.
How much did AMPH change today?
The percentage change in AMPH stock occurred in the recent session was -1.95% while the dollar amount for the price change in AMPH stock was $-0.69.
What price range AMPH stock been trading in?
In the recent session, the day high for AMPH stock was $35.41 while the low for AMPH stock touched on the day was $34.42.
What is the market cap of AMPH currently?
The market value of AMPH currently stands at 1.67 Billion with its latest stock price at $34.66 and 48.14 Million of its shares outstanding.